February 18, 2026

FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer

FDA: Device Delivers Non-invasive Therapy and Supports Care at Home White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with locally advanced pancreatic...

recent articles

Hoping for a better 2021. Best wishes for the holidays and the new...

AI-Powered Automatic Whole Slide Scanner for Malaria Detection XIAMEN, CHINA – Advanced microscope designer and manufacturer Motic China Group Co., a subsidiary of Motic (Xiamen) Electric Group Co. Ltd. (SHE:300341), announced today it...

3DHISTECH, the Digital Pathology Company launches a new diagnostic pathology product line tailored to the needs of routine pathology laboratories. Budapest, Hungary, December 18, 2020 – 3DHISTECH launches a new product line dedicated to...

Artificial Intelligence (AI) is transforming clinical pathology. The full potential of AI can only be achieved by the seamless integration of AI in clinical workflows to support pathologists. During this recorded presentation Aiforia’s...

Vancouver, BC, Canada, December 4, 2020 – ViewsIQ and GenerationsE are pleased to jointly announce their partnership for the worldwide sales representation of GenerationsE’s DeepScene product for AI-driven detection of colorectal cancer....

OR

platinum partners

gold partners

Silver Partners

Media Partners